Related Experiment Video
Updated: Mar 3, 2026

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
Published on: May 16, 2021
Compound Libraries: Recent Advances and Their Applications in Drug Discovery
Zhen Gong1, Guoping Hu1, Qiang Li1
1State Key Laboratory of Lead Compound Research, WuXi AppTec, 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai 200131. China.
Advancements in compound libraries, including DNA-encoded libraries (DELs), enhance small-molecule drug discovery by enabling efficient hit identification for novel targets. These libraries benefit pharmaceutical development and research organizations.
Area of Science:
- Drug discovery and development
- Medicinal chemistry
- Chemical biology
Background:
- Hit identification is crucial for small-molecule drug discovery and the pharmaceutical industry.
- In vitro assay screening of compound libraries is a primary method for hit identification.
- High-throughput screening (HTS) has been impactful but relies on library size and resources.
Purpose of the Study:
- To review the progress and classification of compound libraries.
- To discuss library design methods, focusing on focused libraries.
- To report on the status of compound libraries at WuXi.
Main Methods:
- Systematic literature review from 1986 to 2017.
- Organized research into 5 detailed sections.
- Summarized sources, classifications, and progress in library types.
Main Results:
- Overview of combinatorial and DNA-encoded libraries (DELs).
- Detailed introduction to library design, particularly focused libraries.
- Report on the current state of compound libraries at WuXi.
Conclusions:
- Progress in compound libraries, including drug template libraries, DELs, and focused libraries, aids in identifying better hits for novel drug targets.
- These libraries accelerate hit identification, benefiting academic institutions and small companies.
- Advancements in compound libraries are vital for promoting pharmaceutical industry development, especially for first-in-class drugs.
Related Concept Videos
Drug Discovery: Overview
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Pharmacogenomics: Identification of New Drug Targets
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Ligand Binding Sites
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...

